Plasma Half-Life of Vaped/Inhaled THC
The plasma half-life of inhaled THC from vaping is approximately 1.4-2.5 hours during the initial elimination phase (0-8 hours post-inhalation), based on the most recent pharmacokinetic data.
Pharmacokinetic Profile
The elimination kinetics of inhaled THC follow a biphasic pattern:
Initial Elimination Phase (0-8 hours)
- Half-life: 1.4-2.5 hours 1, 2
- This represents the clinically relevant timeframe for acute psychoactive effects
- A 2010 study modeling high-dose smoked cannabis (up to 69mg THC) reported a median terminal half-life of 150 minutes (2.5 hours) within the 8-hour observation window 1
- An earlier 2007 study found elimination half-lives of 1.4 ± 0.1 hours calculated from 1-6 hours post-smoking 2
Key Pharmacokinetic Parameters
After inhalation, THC demonstrates:
- Rapid absorption: Peak concentrations (Cmax) occur within seconds to minutes, typically around 14 minutes 1
- Psychoactive duration: 2-3 hours 3
- Bioavailability: 10-35% for inhaled THC 3
Important Clinical Caveats
Biphasic Elimination Pattern
The short half-life of 1.4-2.5 hours applies only to the initial distribution and elimination phase. THC exhibits a much longer terminal elimination phase due to:
- High lipid solubility: THC accumulates in adipose tissue and is gradually released 3
- Late elimination phase: In chronic users, the terminal half-life can extend to 17.5-43.5 hours 4
- Detection windows: In frequent users, THC may be detectable in blood for up to 30 days due to redistribution from fat stores 5
User-Dependent Variability
Frequent vs. Occasional Users: Heavy cannabis users (4-25 uses per week) show markedly different kinetics 4:
- May have baseline THC levels of up to 12.3 μg/L before smoking
- Demonstrate similar initial distribution patterns but with significantly higher peak concentrations
- Show prolonged elimination in the absence of acute dosing
Metabolite Half-Lives
The metabolites have longer half-lives than parent THC 2:
- 11-hydroxy-THC (OH-THC): 2.0-3.1 hours
- 11-nor-9-carboxy-THC (COOH-THC): 3.4-6.2 hours
This creates a characteristic metabolite-to-parent ratio that changes over time, useful for distinguishing recent use from residual detection.
Vaping vs. Smoking Comparison
Recent 2026 research found no significant differences between vaporized and smoked cannabis pharmacokinetics 5. Both routes produce:
- Similar peak concentrations
- Comparable elimination patterns
- Equivalent detection windows for recent use markers
The presence of CBD in vaporized cannabis may increase THC plasma levels, with one 2026 study showing higher THC area-under-the-curve (AUC) and Cmax values when CBD was co-administered 6.
Clinical Implications
For therapeutic drug monitoring, preliminary therapeutic reference ranges suggest:
- Pain/symptom relief: 7-30 ng/mL THC 7
- Psychoactive effects: Half-maximum effective concentrations of 7-29 ng/mL 7
The short initial half-life (1.4-2.5 hours) explains why psychoactive effects resolve within 2-3 hours, but does not reflect the prolonged detectability in chronic users due to adipose redistribution 3, 4.